Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline.
Source link
- From the Shanghai upgrade to U.S. regulation: Watch these 5 events to see where crypto markets are heading in 2023
- Inflation is expected to have declined in December, but it may not be enough to stop the Fed
